Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 02:15 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Efficacy of Haloperidol vs. Metoclopramide for Treatment of Acute Headaches and Migraines in the Emergency Department
NCT02972502 · OhioHealth · PHASE4 · terminated · last registry update 2018-10-23 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “PI lapsed institutional training” | – | Registry record, OhioHealth |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against DRD2 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2019-09-27Results posted on the registry: Spanish Breast Cancer Research Group, Aprepitant (NCT01298193)
- 2019-09-09Phase 3 first posted: Christine Oryhan, Opioid Anesthetics + Non Opioid Analgesics (NCT04081545)
- 2019-08-20Results posted on the registry: Vanderbilt University Medical Center, Haloperidol + Ziprasidone (NCT01211522)
- 2019-07-05Results posted on the registry: University of Southern California, Quetiapine + Haloperidol (NCT00457366)
- 2019-06-26Results posted on the registry: Stanford University, Valproic Acid + Placebo (NCT02343575)
- 2019-06-26Also stopped (terminated): Stanford University, Valproic Acid + Placebo (NCT02343575)
- 2019-06-18Also stopped (terminated): University of California, Davis, Ondansetron (NCT03075163)
- 2019-06-12Phase 3 first posted: Newark Beth Israel Medical Center, Lidocaine topical + Prochlorperazine Injection (NCT03984045)
- 2019-06-04Results posted on the registry: University of California, Davis, Ondansetron (NCT03075163)
- 2019-04-03Results posted on the registry: Wake Forest University Health Sciences, 0.5% bupivacaine + Standard Care (NCT01785459)
- 2019-03-11Results posted on the registry: Alexza Pharmaceuticals, Inc., Inhaled placebo + Oral placebo (NCT00543062)
- 2019-03-07Results posted on the registry: Vanderbilt University, Propofol + Sevoflurane (NCT02625181)
- 2019-02-15Also stopped (terminated): University Health Network, Toronto, Cisplatin + Paclitaxel (NCT01083537)
- 2018-11-16Phase 3 first posted: M.D. Anderson Cancer Center, Haloperidol + Lorazepam (NCT03743649)
- 2018-11-07Also stopped (terminated): Merck Sharp & Dohme LLC, Preladenant + Placebo (NCT00693472)
- 2018-11-05Results posted on the registry: Nova Pneuma Inc., Prochlorperazine 0.5 mg IV over 5 sec + Inhaled prochlorperazine 0.625 mg (NCT00610727)
- 2018-10-09Also stopped (terminated): Memorial Sloan Kettering Cancer Center, a drug against DRD2 (NCT02350777)
- 2018-08-24Also stopped (withdrawn): NYU Langone Health, Topiramate + Standard of Care (NCT02643719)
- 2018-08-14Phase 3 first posted: Erasmus Medical Center, Haloperidol + Placebo (NCT03628391)
- 2018-06-11Results posted on the registry: University of Arkansas, Haloperidol + lorazepam + Loxapine (NCT03110900)
- 2018-06-11Also stopped (terminated): University of Arkansas, Haloperidol + lorazepam + Loxapine (NCT03110900)
- 2018-06-06Results posted on the registry: Memorial Sloan Kettering Cancer Center, a drug against DRD2 (NCT02350777)
- 2018-06-06Results posted on the registry: Montefiore Medical Center, Hydromorphone + Prochlorperazine (NCT02389829)
- 2018-05-22Results posted on the registry: Michelle Weckmann, Haldol (NCT03489551)
- 2018-03-21Also stopped (terminated): UMC Utrecht, Haloperidol + Methylphenidate (NCT00599287)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision